{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":3,"sponsored":0,"items":[{"id":"n_oevfd6cb7dkjynprtztq","seq":1459198,"kind":"article","title":"FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL","url":"https://www.pharmacytimes.com/view/fda-approves-pirtobrutinib-for-previously-untreated-cll-sll","published":"2026-10-02T20:55:00Z","seen":"2026-10-03T01:28:11Z","lang":"en","source":{"id":"pharmacytimes.com","name":"pharmacytimes.com","domain":"pharmacytimes.com","outlet":{"wikidata":"Q27712672","name":"Pharmacy times","type":"website","designations":["scientific journal","website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q116622551","name":"pirtobrutinib","type":"other"},{"id":"Q18557229","name":"chronic lymphocytic leukemia and small lymphocytic lymphoma","type":"other"}],"story":"st_ekxsvf5vhi4tjqzed5ta","category":"health","category_p":0.59,"sentiment":"neutral","tone":-0.17,"political":0.15},{"id":"n_ep77polfk6bbuteyhswa","seq":1419182,"kind":"article","title":"Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL","url":"http://www.prnewswire.com/news-releases/lillys-jaypirca-pirtobrutinib-the-first-and-only-approved-non-covalent-btk-inhibitor-receives-expanded-indication-from-us-fda-for-certain-patients-with-previously-untreated-cllsll-302897416.html","published":"2026-10-02T19:30:00Z","seen":"2026-10-02T19:47:13Z","lang":"en","source":{"id":"prnewswire.com","name":"prnewswire.com","domain":"prnewswire.com","outlet":{"wikidata":"Q376399","name":"PR Newswire","type":"other","country":"US","designations":["business","information resource"]}},"via":"gdelt-gkg-english","topics":["economy","health","science","education"],"authors":["Eli Lilly","Company"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q116622551","name":"pirtobrutinib","type":"other"},{"id":"Q18557229","name":"chronic lymphocytic leukemia and small lymphocytic lymphoma","type":"other"}],"story":"st_ep77polfk6bbuteyhswa","category":"health","category_p":0.67,"sentiment":"neutral","tone":-0.48,"political":0.13},{"id":"n_aygcky4snstfjhyrakdq","seq":408616,"kind":"article","title":"Innovent's Jaypirca Gets Expanded NMPA Approval For CLL/SLL","url":"https://www.rttnews.com/3694273/innovent-s-jaypirca-gets-expanded-nmpa-approval-for-cll-sll.aspx","published":"2026-09-28T10:39:00Z","seen":"2026-09-28T11:11:39Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["business","economy","health"],"entities":[{"id":"Q30296199","name":"Innovent","type":"org"},{"id":"Q116622551","name":"pirtobrutinib","type":"other"},{"id":"Q17091299","name":"National Music Publishers' Association","type":"org"},{"id":"Q18557229","name":"chronic lymphocytic leukemia and small lymphocytic lymphoma","type":"other"}],"story":"st_aygcky4snstfjhyrakdq","category":"science-technology","category_p":0.44,"category2":"economy-business","sentiment":"positive","tone":0.21,"political":0.05}]}